DAF/Crry double deficiency in mice exacerbates nephrotoxic serum-induced proteinuria despite markedly reduced systemic complement activity

Molecular Immunology

Volumn 44, Issue 1-3, 2007, Pages 139-146

  Miwa, Takashi ^a   Zhou, Lin ^a   Tudoran, Ruxandra ^b   Lambris, John D ^b   Madaio, Michael P ^b   Nangaku, Masaomi ^c   Molina, Hector ^d   Song, Wen Chao ^a  

^a Institute for Translational Medicine   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anti GBM; CD55; Complement; Crry; DAF; Glomerulonephritis; Inflammation

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT RECEPTOR 1 RELATED PROTEIN Y; DECAY ACCELERATING FACTOR; PROTEIN; UNCLASSIFIED DRUG; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT DEFICIENCY; CONTROLLED STUDY; CROSS BREEDING; DISEASE PREDISPOSITION; GLOMERULONEPHRITIS; IMMUNE COMPLEX NEPHRITIS; KNOCKOUT MOUSE; MOUSE; NONHUMAN; OPSONIZATION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEINURIA; SPECIES COMPARISON; TISSUE INJURY;

ANIMALS; ANTIGENS, CD55; COMPLEMENT ACTIVATION; COMPLEMENT C3; FEMALE; GLOMERULAR BASEMENT MEMBRANE; IMMUNIZATION; MALE; MICE; MICE, KNOCKOUT; PROTEINURIA; RABBITS; RECEPTORS, COMPLEMENT; SHEEP;

RODENTIA;

EID: 33750458032     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2006.06.023     Document Type: Article

References (31)

1. Adler S., and Couser W. Immunologic mechanisms of renal disease. Am. J. Med. Sci. 289 (1985) 55-60
2. Chan O.T., Hannum L.G., Haberman A.M., Madaio M.P., and Shlomchik M.J. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J. Exp. Med. 189 (1999) 1639-1648
3. Chan O.T., Madaio M.P., and Shlomchik M.J. The central and multiple roles of B cells in lupus pathogenesis. Immunol. Rev. 169 (1999) 107-121
4. Clynes R., Dumitru C., and Ravetch J.V. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279 (1998) 1052-1054
5. Clynes R., and Ravetch J.V. Cytotoxic antibodies trigger inflammation through Fc receptors. Immunity 3 (1995) 21-26
6. Couser W.G., Baker P.J., and Adler S. Complement and the direct mediation of immune glomerular injury: a new perspective. Kidney Int. 28 (1985) 879-890
7. Holers V.M., Kinoshita T., and Molina H. The evolution of mouse and human complement C3-binding proteins: divergence of form but conservation of function. Immunol. Today 13 (1992) 231-236
8. Kim D.D., and Song W.C. Membrane complement regulatory proteins. Clin. Immunol. 118 (2006) 127-136
9. Krych M., Molina H., and Atkinson J.P. CD35: complement receptor type 1. J. Biol. Regul. Homeost. Agents 13 (1999) 229-233
10. Li B., Sallee C., Dehoff M., Foley S., Molina H., and Holers V.M. Mouse Crry/p65. Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF. J. Immunol. 151 (1993) 4295-4305
11. Liszewski M.K., Post T.W., and Atkinson J.P. Membrane cofactor protein (MCP or CD46): newest member of the regulators of complement activation gene cluster. Annu. Rev. Immunol. 9 (1991) 431-455
12. Lublin D.M., and Atkinson J.P. Decay-accelerating factor: biochemistry, molecular biology, and function. Annu. Rev. Immunol. 7 (1989) 35-58
13. Mao D., Wu X., Deppong C., Friend L.D., Dolecki G., Nelson D.M., and Molina H. Negligible role of antibodies and C5 in pregnancy loss associated exclusively with C3-dependent mechanisms through complement alternative pathway. Immunity 19 (2003) 813-822
14. Mastellos D., Prechl J., Laszlo G., Papp K., Olah E., Argyropoulos E., Franchini S., Tudoran R., Markiewski M., Lambris J.D., and Erdei A. Novel monoclonal antibodies against mouse C3 interfering with complement activation: description of fine specificity and applications to various immunoassays. Mol. Immunol. 40 (2004) 1213-1221
15. Miwa T., Maldonado M.A., Zhou L., Sun X., Luo H.Y., Cai D., Werth V.P., Madaio M.P., Eisenberg R.A., and Song W.C. Deletion of decay-accelerating factor (CD55) exacerbates autoimmune disease development in MRL/lpr mice. Am. J. Pathol. 161 (2002) 1077-1086
16. Miwa T., and Song W.C. Membrane complement regulatory proteins: insight from animal studies and relevance to human diseases. Int. Immunopharmacol. 1 (2001) 445-459
17. Miwa T., Sun X., Ohta R., Okada N., Harris C.L., Morgan B.P., and Song W.C. Characterization of glycosylphosphatidylinositol-anchored decay accelerating factor (GPI-DAF) and transmembrane DAF gene expression in wild-type and GPI-DAF gene knockout mice using polyclonal and monoclonal antibodies with dual or single specificity. Immunology 104 (2001) 207-214
18. Miwa T., Zhou L., Hilliard B., Molina H., and Song W.C. Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack. Blood 99 (2002) 3707-3716
19. Molina H., Miwa T., Zhou L., Hilliard B., Mastellos D., Maldonado M.A., Lambris J.D., and Song W.C. Complement-mediated clearance of erythrocytes: mechanism and delineation of the regulatory roles of Crry and DAF. Decay-accelerating factor. Blood 100 (2002) 4544-4549
20. Quigg R.J., He C., Lim A., Berthiaume D., Alexander J.J., Kraus D., and Holers V.M. Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injury. J. Exp. Med. 188 (1998) 1321-1331
21. Quigg R.J., Kozono Y., Berthiaume D., Lim A., Salant D.J., Weinfeld A., Griffin P., Kremmer E., and Holers V.M. Blockade of antibody-induced glomerulonephritis with Crry-Ig, a soluble murine complement inhibitor. J. Immunol. 160 (1998) 4553-4560
22. Sogabe H., Nangaku M., Ishibashi Y., Wada T., Fujita T., Sun X., Miwa T., Madaio M.P., and Song W.C. Increased susceptibility of decay-accelerating factor deficient mice to anti-glomerular basement membrane glomerulonephritis. J. Immunol. 167 (2001) 2791-2797
23. Song W.C. Membrane complement regulatory proteins in autoimmune and inflammatory tissue injury. Curr. Direct. Autoimm. 7 (2004) 181-199
24. Song W.C., Deng C., Raszmann K., Moore R., Newbold R., McLachlan J.A., and Negishi M. Mouse decay-accelerating factor: selective and tissue-specific induction by estrogen of the gene encoding the glycosylphosphatidylinositol-anchored form. J. Immunol. 157 (1996) 4166-4172
25. Spicer A.P., Seldin M.F., and Gendler S.J. Molecular cloning and chromosomal localization of the mouse decay-accelerating factor genes. Duplicated genes encode glycosylphosphatidylinositol-anchored and transmembrane forms. J. Immunol. 155 (1995) 3079-3091
26. Sun X., Funk C.D., Deng C., Sahu A., Lambris J.D., and Song W.C. Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 628-633
27. Takizawa H., Takahashi K., Murakami T., Okada N., and Okada H. Species-specific restriction of complement by HRF20 (CD59) generated by cDNA transfection. Eur. J. Immunol. 22 (1992) 1943-1946
28. Walport M.J. Complement. First of two parts. N. Engl. J. Med. 344 (2001) 1058-1066
29. Walport M.J. Complement. Second of two parts. N. Engl. J. Med. 344 (2001) 1140-1144
30. Xu C., Mao D., Holers V.M., Palanca B., Cheng A.M., and Molina H. A critical role for murine complement regulator Crry in fetomaternal tolerance. Science 287 (2000) 498-501
31. Yamada K., Miwa T., Liu J., Nangaku M., and Song W.C. Critical protection from renal ischemia reperfusion injury by CD55 and CD59. J. Immunol. 172 (2004) 3869-3875